Zhengye Biotechnology Holding Limited
ZYBT
$6.70
-$2.79-29.40%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.57M | 2.19M | 2.81M | 3.63M | 4.47M |
| Total Depreciation and Amortization | 3.36M | 3.30M | 3.23M | 3.30M | 3.38M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 915.00K | 628.10K | 336.50K | 1.09M | 1.85M |
| Change in Net Operating Assets | -134.90K | 547.20K | 1.23M | -858.00K | -3.00M |
| Cash from Operations | 5.71M | 6.66M | 7.60M | 7.15M | 6.71M |
| Capital Expenditure | -1.89M | -1.50M | -1.11M | -1.07M | -1.03M |
| Sale of Property, Plant, and Equipment | 15.00K | 80.80K | 146.40K | 146.40K | 146.40K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.97M | -2.34M | -2.70M | -1.73M | -750.60K |
| Cash from Investing | -3.84M | -3.76M | -3.67M | -2.65M | -1.63M |
| Total Debt Issued | 90.27M | 85.08M | 79.90M | 79.88M | 79.86M |
| Total Debt Repaid | -92.86M | -87.61M | -82.36M | -68.63M | -54.89M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.22M | -3.70M | -5.17M | -5.36M | -5.57M |
| Other Financing Activities | -3.51M | -4.27M | -5.03M | -4.77M | -4.50M |
| Cash from Financing | -3.07M | -4.64M | -6.20M | -4.40M | -2.58M |
| Foreign Exchange rate Adjustments | 23.30K | 11.80K | 200.00 | 100.00 | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.18M | -1.72M | -2.27M | 96.30K | 2.50M |